Oryzon Genomics S.A. ORYZF
Set alert
3.10 USD 0.00 0.00%
At close · Oct 29
3.45 Day range 3.45
3.10 52-week range 3.70
- YTD
- -7.81%
- 1 year
- -14.20%
- Open
- 3.45
- Prev close
- 3.10
- Mkt cap
- 253.86M
- Vol
- 100
- Avg vol
- 717
- EPS
- -0.03
- P/E
- 0.00
More statistics
- Low
- 3.45
- High
- 3.45
2Y chart
Signals (42)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| RSI: Oversold | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| RSI: Oversold | Jul 27, 2026 | 3 months ago |
| RSI: Overbought | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | May 19, 2026 | 5 months ago |
| RSI: Overbought | May 19, 2026 | 5 months ago |
| MACD: Buy Signal | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| RSI: Oversold | Mar 5, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 17, 2026 | 8 months ago |
| SMA: Bullish | Jan 27, 2026 | 9 months ago |
| RSI: Overbought | Jan 27, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Nov 17, 2025 | 11 months ago |
| RSI: Oversold | Nov 17, 2025 | 11 months ago |
| MACD: Sell Signal | Sep 30, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 27, 2025 | 1 year ago |
| SMA: Bullish | Jun 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 9, 2025 | 1 year ago |
| RSI: Overbought | Jun 9, 2025 | 1 year ago |
| SMA: Bearish | May 9, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 21, 2025 | 1 year ago |
| SMA: Bullish | Mar 3, 2025 | 1 year ago |
| RSI: Overbought | Mar 3, 2025 | 1 year ago |
| RSI: Oversold | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 24, 2024 | 1 year ago |
| RSI: Oversold | Dec 3, 2024 | 1 year ago |
| RSI: Overbought | Nov 27, 2024 | 1 year ago |
News
- ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
- ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
- ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
- ORYZON Expands Global Patent Protection for Iadademstat with Grant Decision in Japan Covering Combinations with PD-1/PD-L1 Inhibitors
- ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders' Meeting
- ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2025
- ORYZON Announces First‑Patient‑In (FPI) in RESTORE Phase Ib Trial of Iadademstat in Sickle Cell Disease
- ORYZON to Participate in Upcoming Events in November
- ORYZON Receives Feedback From the FDA in Response to the Submitted Phase III Protocol in Borderline Personality Disorder
- ORYZON Strengthens Patent Portfolio for iadademstat with European Grant Decision Covering Combinations with PD1/PD-L1 Inhibitors
Your note
Sign in to keep a note on ORYZF — it syncs with the Stock Master app.